Clinical Trial Update: Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a personalized antiemetic regimen guided by patients' pharmacogenetic profile in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING